TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a bioactive coating aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. The coating incorporates calcium phosphate derived from hydroxyapatite and features nitrogen compounds linked to nitric oxide production. Laboratory experiments showed that human mesenchymal stem cells survived significantly better on coated surfaces compared to uncoated titanium. The team investigated the coating’s structure, chemistry, mechanical strength, and biological response. Their peer-reviewed results were published in Applied Surface Science in 2026.
Researchers at Tomsk Polytechnic University developed these experimental coatings using reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen and argon ratios during deposition to see how each mixture affected the surface properties. Five conditions were tested, from pure nitrogen to pure argon. The team measured coating thickness, surface morphology, hardness, wettability, and chemical composition. They also ran lab tests to analyze how living human cells responded to the modified titanium.
The physical characteristics of the coatings were influenced by argon content. Surfaces created with pure argon were denser and harder than those made with pure nitrogen. As argon levels increased, coating thickness also grew. Chemical analysis identified nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. The team then compared the behavior of human mesenchymal stem cells on coated titanium versus uncoated titanium. They assessed cell viability and markers related to bone-cell development.
Enhanced cell survival observed on coated surfaces
The experiments showed that coated surfaces supported cell survival more effectively than uncoated titanium. After seven days, coatings with higher nitrogen content also reduced activity in certain genes linked to early bone-cell differentiation. Despite this, cells still maintained their ability to form bone. All tests were conducted in controlled laboratory conditions using human mesenchymal stem cells. The study did not involve testing in patients nor did it evaluate the clinical performance of medical implants.
The biomedical assessment was carried out by Immanuel Kant Baltic Federal University and Siberian State Medical University. The research team also included scientists from Saint Petersburg State University. The project was supported by Russia’s state science program. The goal was to identify gas mixtures that could yield favorable physical, chemical, and biological properties in coatings. Hydroxyapatite is already used in implant coatings because its calcium phosphate makeup resembles human bone mineral.
Current research remains in early testing stages
The researchers plan further testing beyond the initial seven-day cell viability analysis. They aim to study stem cells over 10 to 28 days. Additional work will examine how quickly the coatings dissolve and measure nitric oxide release into surrounding tissue in living organisms. These future studies were not included in the published laboratory results. The current research focuses on coated titanium substrates, their material properties, and cell responses in vitro, rather than clinical outcomes in orthopaedic patients.
The results offer detailed lab data on how variations in nitrogen and argon ratios affect calcium phosphate coatings on titanium surfaces. Differences in thickness, density, hardness, chemical bonds, and cellular responses across gas mixtures were documented. The study confirmed that coated samples had higher stem-cell survival rates than uncoated titanium under the test conditions. However, these findings are preliminary, and safety or efficacy in human patients has not yet been established. Additional biological testing is needed to evaluate properties not addressed in this study.